Supriya Lifescience submits board meeting intimation

27 Jul 2023 Evaluate
In terms of Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that a meeting of the Board of Directors of the Company will be held on Thursday, August 3, 2023, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. This is further to informed that with reference to our letter dated June 28, 2023 and in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company’s Code of Conduct for Prevention of Insider Trading, the 'Trading Window’ for dealing in the securities of the Company shall continue to remain closed till 48 hours after announcement of Unaudited Financial Results for the quarter ended June 30, 2023.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

637.70 13.85 (2.22%)
01-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.